New study shows tirzepatide reduces LV mass and heart fat in obesity-related HFpEF, potentially improving heart failure outcomes.

The Partnership for Safe Medicines today released a new report that found suspicious, unauthorized, and illegal ingredients for popular diabetes and obesity injectables (commonly known as weight loss ...

The new weight loss drug offers promising results for those who are overweight or obese. Learn about how Zepbound works, its ...

Nikki Laine has been taking the weight-loss drug Mounjaro for just over three weeks and has described it as "life-changing" ...

Adults with type 2 diabetes receiving tirzepatide had significantly greater declines in urine albumin-to-creatinine ratio ...

A telehealth company partnered with a pharmacy that lacked a required license, raising doubts about the safety and efficacy ...

A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and ...

Researchers found that women with hypertension who followed a very low-calorie ketogenic diet had lower systolic and diastolic blood pressure at 6 months than those who participated in intermittent ...

A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...

Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.

The main results of the SUMMIT trial, reported last year, showed that tirzepatide—a dual glucose-dependent insulinotropic ...

A post hoc analysis of trial data published in Diabetes Care found that adults with type 2 diabetes receiving tirzepatide ...